Literature DB >> 6354433

Drug resistance in Chinese hamster lung and mouse tumor cells.

J L Biedler, T D Chang, M B Meyers, R H Peterson, B A Spengler.   

Abstract

Studies of Chinese hamster and mouse cells with high levels of acquired resistance to dactinomycin, daunorubicin, or vincristine have shown that these different permeability mutants all display similar phenotypic alterations: dramatic changes toward normal cell morphology and growth behavior and substantially reduced oncogenic potential. All three resistant cell types show increased expression of a high molecular weight plasma membrane glycoprotein species, gp150. Uniquely, vincristine-resistant cells contain gene amplification-associated chromosome abnormalities (homogeneously staining regions or double minute chromosomes), and they oversynthesize a low molecular weight cytosolic protein (V19). Cells grown in the absence of drug are phenotypically unstable. Revertant cells decline in resistance, length or number of homogeneously staining regions or double minute chromosomes, and expression of gp150 and V19. These proteins are thus candidate products of amplified genes which may or may not be manifested cytogenetically. The phenomena of drug resistance and reverse transformation are currently being addressed in protein phosphorylation studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354433

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  28 in total

1.  The multidrug-resistance gene MDR1 is expressed in human glial tumors.

Authors:  I Becker; K F Becker; R Meyermann; V Höllt
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells.

Authors:  M B Meyers; V J Merluzzi; B A Spengler; J L Biedler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells.

Authors:  P Gros; J Croop; I Roninson; A Varshavsky; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

4.  Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.

Authors:  A T Fojo; J Whang-Peng; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.

Authors:  D Roberts; T Lee; E Parganas; L Wiggins; J Yalowich; R Ashmun
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 6.  Multidrug resistance.

Authors:  V Ling; J Gerlach; N Kartner
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

7.  Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines.

Authors:  M H de Bruijn; A M Van der Bliek; J L Biedler; P Borst
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

8.  Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells.

Authors:  G Vasanthakumar; N K Ahmed
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results. The Kyushu University Urological Oncology Group.

Authors:  S Naito; T Ueda; S Kotoh; A Iguchi; K Sagiyama; Y Hiratsuka; Y Osada; A Ariyoshi; T Omoto; J Kumazawa
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  Reverse transformation of multidrug-resistant cells.

Authors:  J L Biedler; B A Spengler
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.